Pfizer’s Global Medical Grants: NASH – Future of Non-invasive Diagnosis Technologies

The submitted proposals should aim to inform the scientific and clinical community and to advance the discussion around non-invasive biomarkers and diagnostic tools for NASH (Nonalcoholic steatohepatitis).

Funding & duration

Up to US $250,000 (approx. AUD $387,000).

Submission requirements & due date

Further information

Need help?

This entry was posted in Funding by Award Type, Funding by Faculty, Grants (Project Funds), Health & Medical Sciences, International Funding. Bookmark the permalink.

Comments are closed.